CDC Report Highlights Opioid Prescription Disparities: How Does Arkansas Compare?

Why it matters locally: The CDC's report on opioid prescription rates has significant implications for Arkansas residents, businesses, and the state government. With a population of over 3 million, Arkansas is not immune to the opioid crisis and the potential health consequences associated with elevated prescription rates. Understanding where Arkansas stands relative to other states in opioid prescriptions is crucial for informed policy decisions, allocation of resources for addiction treatment and prevention programs, and addressing potential overdose risks among Arkansans. High prescription rates can strain local healthcare systems and impact public health spending.

---

Atlanta — A Centers for Disease Control and Prevention (CDC) report, titled "Vital Signs,” released data revealing significant variations in opioid painkiller prescriptions across different states in 2012. The report emphasizes the potential risks associated with opioid use, specifically the danger of overdose. The report indicates that healthcare providers nationwide wrote approximately 259 million prescriptions for opioid painkillers in 2012. However, prescription rates differed substantially from state to state. The CDC's “Vital Signs” report aims to provide data and information on critical health issues. This particular report focused on prescription opioid use and its potential implications.